AzTrials
AzTrials

Chronic PainNCT06368531

Long-term Monitoring of Sleep with Ear-EEG in Patients with Chronic Pain

An observational study of Chronic Pain and Insomnia, run by Odense University Hospital at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Insomnia is reported by more than 50% of patients with chronic pain. In this study, the investigators aim to advance the understanding of physiological sleep in individuals with chronic pain. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Chronic Pain, Insomnia
How many people
25 participants
Where
1 siteDenmark
Study dates
4 Apr 2024to 27 Nov 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Subjects eligible for this study are individuals with chronic pain in compliance with the inclusion/exclusion criteria listed below. The health status of the subjects is assessed by self-reports. Inclusion and exclusion criteria ensure generalizability of study results for a broad population of individuals with chronic pain, and only serious concomitant conditions, which could interfere with the study procedures should prevent subjects from entering the study.

Who may be able to join

  • For a subject to be eligible, all inclusion criteria must be answered "yes":
  • Understand and write Danish.
  • Pain present on most days or every day during the past 3 months.
  • Pain limits daily activities or work on some days, most days or every day during the past 3 months.
  • Pain intensity equal to or larger than 4 on 0-10 Numeric Rating Scale [NRS] within the last week.
  • Informed consent obtained before any study related activities.

Who cannot join

  • For a subject to be eligible, all exclusion criteria must be answered "no":
  • Previous stroke or cerebral haemorrhage and any other structural cerebral disease.
  • Obstructive sleep apnoea (Defined as yes to 3 or more questions in the STOP-BANG questionnaire for women and 4 or more questions for men).
  • Teeth grinding (bruxism).
  • Pregnancy or lactation (Pregnancy is screened for through self-reporting as no risks regarding pregnancy have been identified for the described study procedures).
  • Narrow or malformed ear canals or piercings, making ear-EEG infeasible.
  • Allergic contact dermatitis caused by metals or generally prone to skin irritation.
  • People judged incapable, by the investigator, of understanding the participant instruction or who are not capable of carrying through the investigation.

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Pain Center, Department of Anesthesiology and Intensive Care Medicine, University Hospital Odense

    Odense, 5000

Other trials in Denmark

About this study

Insomnia is reported by more than 50% of patients with chronic pain. In this study, the investigators aim to advance the understanding of physiological sleep in individuals with chronic pain. To do this the investigators will monitor at-home sleep with an ear-EEG over 20 nights in patients with chronic pain and collect self-reported measures of sleep and pain. The collected data will be used to explore and characterize intra-individual variations in sleep metrics (e.g. total sleep time, time in each sleep stage (N1, N2, N3, REM), sleep latency, REM stage latency, wake after sleep onset, sleep efficiency, number of arousals and arousal index) over 20 nights.

Medical subject headings
Chronic Pain, Sleep Initiation and Maintenance Disorders

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. sleep period time (SPT) from Ear EEG

    Sleep metrics will be derived from the EEG assessments as recommended by the American Academy of Sleep Medicine (AASM).

    Measured: 5 nights every week for 4 weeks

  2. Qualitative sleep parameters obtained from sleep diary.

    Sleep diary is completed in the morning

    Measured: Sleep diary is completed 5 mornings every week for 4 weeks

  3. Pain intensity rating

    Average pain intensity during the last day and current pain intensity in the morning will be assessed on an 11-point numeric rating scale (NRS) ranging from 0 (no pain) to 10 (worst imaginable pain)

    Measured: Pain intensity rating is completed 5 mornings every week for 4 weeks

  4. Time from sleep onset until final awakening (TST) from Ear EEG

    Sleep metrics will be derived from the EEG assessments as recommended by the American Academy of Sleep Medicine (AASM).

    Measured: 5 nights every week for 4 weeks

  5. Sleep efficiency (SE) from Ear EEG

    Sleep metrics will be derived from the EEG assessments as recommended by the American Academy of Sleep Medicine (AASM). SE is the ratio of TST to time in bed / 100%

    Measured: 5 nights every week for 4 weeks

  6. Sleep onset latency (SOL) from Ear EEG

    Sleep metrics will be derived from the EEG assessments as recommended by the American Academy of Sleep Medicine (AASM).

    Measured: 5 nights every week for 4 weeks

  7. Wake after sleep onset (WASO) from Ear EEG

    Sleep metrics will be derived from the EEG assessments as recommended by the American Academy of Sleep Medicine (AASM).

    Measured: 5 nights every week for 4 weeks

  8. REM sleep latency from Ear EEG

    Sleep metrics will be derived from the EEG assessments as recommended by the American Academy of Sleep Medicine (AASM).

    Measured: 5 nights every week for 4 weeks

  9. Time from sleep onset until first epoch of REM stage sleep from Ear EEG

    Sleep metrics will be derived from the EEG assessments as recommended by the American Academy of Sleep Medicine (AASM).

    Measured: 5 nights every week for 4 weeks

  10. Amount of wake and stage N1, N2, N3, and R sleep as a percentage of SPT from Ear EEG

    Sleep metrics will be derived from the EEG assessments as recommended by the American Academy of Sleep Medicine (AASM).

    Measured: 5 nights every week for 4 weeks

  11. Number of awakenings within TST from Ear EEG

    Sleep metrics will be derived from the EEG assessments as recommended by the American Academy of Sleep Medicine (AASM).

    Measured: 5 nights every week for 4 weeks

  12. Arousal index which is number of arousals per hour from Ear EEG

    Sleep metrics will be derived from the EEG assessments as recommended by the American Academy of Sleep Medicine (AASM).

    Measured: 5 nights every week for 4 weeks

Secondary outcomes (3)
  1. Ease-of-use and Comfort with ear EEG

    Three 0-10 questions are used: 1) How did you experience falling asleep with the ear EEG device, 2) How did you experience sleeping with the ear EEG device?, 3) How would you rate your experience of soreness or discomfort in your ears after sleeping with the device? A lower sum score is worse.

    Measured: Completed every morning after ear EEG first 2 weeks and at end of study

  2. Adverse device effects

    Any adverse device effect defined as an adverse effect related to the use of the ear EEG

    Measured: Baseline, after 2 weeks, after 6 weeks

  3. Polysomnography

    Polysomnography (PSG) is used in this study to ensure that the data that comes out of the automatic ear-EEG based sleep scoring matches the clinicians sleep scores based on the PSG. It will enable further development of the existing algorithm for automating the data analysis.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Apr 2024
  2. Study start4 Apr 2024
  3. Primary completion27 Nov 2024
  4. Study completion27 Nov 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06368531
Sponsor's protocol ID
2314270
Status last verified
Mar 2025
First submitted
26 Mar 2024
Last updated
24 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Vaegter HB, Banluesombatkul N, Olsen MLS, Kilic K, Thomsen MD, Hemmsen MC, Kidmose P, Thorlund JB. Temporal Associations Between Physiological Sleep and Next-Day Pain Intensity in Individuals With Activity-Limiting Chronic Pain: A Multiple Night At-Home Ear-EEG Sleep-Monitoring Study. J Sleep Res. 2026 Nov 5:e70488. doi: 10.1111/jsr.70488. Online ahead of print.

    PubMed 42984383

Questions about this trial

What is this clinical trial studying?

An observational study of Chronic Pain and Insomnia, run by Odense University Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

sleep period time (SPT) from Ear EEG (time frame: 5 nights every week for 4 weeks). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06368531, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in